US EditionPublished • loading... • Updated
GLP-1 RA Use Associated with Lower 5-Year Mortality in Colon Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Summary by targetedonc.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
GLP-1 RA Use Associated with Lower 5-Year Mortality in Colon Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Recent research reveals that GLP-1 receptor agonists significantly lower 5-year mortality rates in colon cancer patients, highlighting their potential in cancer treatment.
Natalie Phelps, whose clinical trial was delayed due to RIFs, dies of colon cancer
Natalie Phelps, a 43-year-old mother of two, died Nov. 9 from colorectal cancer. This content is for Group 1 - Individual Seat, Individual Subscription - Annual ($555), Individual Subscription - Monthly ($55), Introductory Subscription - non-renewing ($60), and Sponsored account members only. Visit the site and log in/register to read.The post Natalie Phelps, whose clinical trial was delayed due to RIFs, dies of colon cancer appeared first on T…
Coverage Details
Total News Sources3
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
